Suvoda LLC, a global clinical trial technology company specializing in complex therapeutic areas such as oncology, central nervous system (CNS), and rare diseases, has...
CytoReason, a leader in developing computational disease models for predictive insights, announced it secured an aggregated $80 million from OurCrowd, NVIDIA, Pfizer, and Thermo...